Jennifer M. Wang

Jennifer M. Wang

Auto-generated profile, based on publicly available information

Jennifer M. Wang

Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2023 in Chest
Verified
Journal Article
Closed access
JCJonathan H. Chung
Jonathan H. Chung
LCLydia Chelala
Lydia Chelala
JPJanelle Vu Pugashetti
Janelle Vu Pugashetti
JWJennifer M. Wang
Jennifer M. Wang
AAAyodeji Adegunsoye
Ayodeji Adegunsoye
JOJustin M. Oldham
Justin M. Oldham

21 April 2023 in Frontiers in Physiology
Verified
Journal Article
Open access
JWJennifer M. Wang
Jennifer M. Wang
WLWassim W. Labaki
Wassim W. Labaki
SMSusan Murray
Susan Murray
FMFernando J. Martinez
Fernando J. Martinez
JCJeffrey L. Curtis
Jeffrey L. Curtis
CHCharles Hatt
Charles Hatt
Purpose: The purpose of this study was to train and validate machine learning models for predicting rapid decline of forced expiratory volume in 1 s (FEV1) in individuals with a smoking history at-risk-for chronic obstructive pulmonary disease (COPD), Global Initiative for Chronic Obstructive Lung Disease (GOLD 0), or with mild-to-moderate (GOLD 1–2) COPD. We trained multiple models to predict rapid FEV1 decline using demographic, clinical and radiologic biomarker data. Training and internal validation data were obtained from the COPDGene study and prediction models were validated against the SPIROMICS cohort.Methods: We used GOLD 0–2 participants (n = 3,821) from COPDGene (60.0 ± 8.8 years, 49.9% male) for variable selection and model training. Accelerated lung function decline was defined as a mean drop in FEV1% predicted of > 1.5%/year at 5-year follow-up. We built logistic regression models predicting accelerated decline based on 22 chest CT imaging biomarker, pulmonary function, symptom, and demographic features. Models were validated using n = 885 SPIROMICS subjects (63.6 ± 8.6 years, 47.8% male).Results: The most important variables for predicting FEV1 decline in GOLD 0 participants were bronchodilator responsiveness (BDR), post bronchodilator FEV1% predicted (FEV1.pp.post), and CT-derived expiratory lung volume; among GOLD 1 and 2 subjects, they were BDR, age, and PRMlower lobes fSAD. In the validation cohort, GOLD 0 and GOLD 1–2 full variable models had significant predictive performance with AUCs of 0.620 ± 0.081 (p = 0.041) and 0.640 ± 0.059 (p < 0.001). Subjects with higher model-derived risk scores had significantly greater odds of FEV1 decline than those with lower scores.Conclusion: Predicting FEV1 decline in at-risk patients remains challenging but a combination of clinical, physiologic and imaging variables provided the best performance across two COPD cohorts.

1 October 2025 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
JWJennifer M. Wang
Jennifer M. Wang
AAAyodeji Adegunsoye
Ayodeji Adegunsoye
JPJanelle Vu Pugashetti
Janelle Vu Pugashetti
CLCathryn T. Lee
Cathryn T. Lee
SMSusan Murray
Susan Murray
JOJustin M. Oldham
Justin M. Oldham
Rationale: Progressive pulmonary fibrosis (PPF) is common in patients with fibrotic interstitial lung disease (ILD) and leads to high mortality. Although PPF guideline criteria include computed tomography (CT)-based progression, these measures are qualitative and prone to interreader variability. Quantitative computed tomography (qCT) measurements have the potential to overcome this limitation. Objectives: The objectives of this study were to determine whether changes in qCT measures of pulmonary fibrosis are associated with transplant-free survival (TFS) in a diverse ILD cohort and establish a quantitative computed tomography measure of progressive pulmonary fibrosis (qctPPF). Methods: A retrospective cohort analysis was performed in individuals with fibrotic ILD, including idiopathic pulmonary fibrosis (n = 350), who underwent serial chest CT for clinical indications. Commercially available software was used to generate qCT measures of pulmonary fibrosis, which were tested for association with 2-year TFS using a multivariable Cox proportional hazards model. Iterative modeling was then performed to develop a composite qctPPF measure. Results were validated in an independent ILD cohort (n = 92). Measurements and Main Results: Increasing ground-glass opacity and decreasing lung volume showed consistent association with decreased TFS across cohorts when modeled continuously and dichotomously. qctPPF classification was associated with a greater than threefold increased hazard of death or transplant in the test (hazard ratio, 4.41; 95% confidence interval, 2.77–7.03) and validation (hazard ratio, 3.54; 95% confidence interval, 1.62–7.71) cohorts. Agreement between qctPPF and radiologist-determined PPF was poor (κ = 0.20), with qctPPF classification maintaining prognostic significance when discordant with radiologist interpretation. Conclusions: Changes in qCT measures are associated with clinically relevant outcomes and could improve PPF classification.

1 April 2022 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
JWJennifer M Wang
Jennifer M Wang
SRSundaresh Ram
Sundaresh Ram
WLWassim W Labaki
Wassim W Labaki
MHMeiLan K Han
MeiLan K Han
CGCraig J. Galbán
Craig J. Galbán
Chronic obstructive pulmonary disease (COPD) is heterogenous in its clinical manifestations and disease progression. Patients often have disease courses that are difficult to predict with readily available data, such as lung function testing. The ability to better classify COPD into well-defined groups will allow researchers and clinicians to tailor novel therapies, monitor their effects, and improve patient-centered outcomes. Different modalities of assessing these COPD phenotypes are actively being studied, and an area of great promise includes the use of quantitative computed tomography (QCT) techniques focused on key features such as airway anatomy, lung density, and vascular morphology. Over the last few decades, companies around the world have commercialized automated CT software packages that have proven immensely useful in these endeavors. This article reviews the key features of several commercial platforms, including the technologies they are based on, the metrics they can generate, and their clinical correlations and applications. While such tools are increasingly being used in research and clinical settings, they have yet to be consistently adopted for diagnostic work-up and treatment planning, and their full potential remains to be explored.

5 February 2010 in The Journal of Physical Chemistry B
Verified
Journal Article
Open access
ADAndrei K. Dioumaev
Andrei K. Dioumaev
JWJennifer M. Wang
Jennifer M. Wang
JLJanos K. Lanyi
Janos K. Lanyi
Low-temperature FTIR spectroscopy of bacteriorhodopsin and xanthorhodopsin was used to elucidate the number of K-like bathochromic states, their sequence, and their contributions to the photoequilibrium mixtures created by illumination at 80−180 K. We conclude that in bacteriorhodopsin the photocycle includes three distinct K-like states in the sequence , and similarly in xanthorhodopsin. K0 is the main fraction in the mixture at 77 K that is formed from J. K0 becomes thermally unstable above ∼50 K in both proteins. At 77 K, both J-to-K0 and K0-to-KE transitions occur and, contrarily to long-standing belief, cryogenic trapping at 77 K does not produce a pure K state but a mixture of the two states, K0 and KE, with contributions from KE of ∼15 and ∼10% in the two retinal proteins, respectively. Raising the temperature leads to increasing conversion of K0 to KE, and the two states coexist (without contamination from non-K-like states) in the 80−140 K range in bacteriorhodopsin, and in the 80−190 K range in xanthorhodopsin. Temperature perturbation experiments in these regions of coexistence revealed that, in spite of the observation of apparently stable mixtures of K0 and KE, the two states are not in thermally controlled equilibrium. The K0-to-KE transition is unidirectional, and the partial transformation to KE is due to distributed kinetics, which governs the photocycle dynamics at temperatures below ∼245 K (Dioumaev and Lanyi, Biochemistry 2008, 47, 11125−11133). From spectral deconvolution, we conclude that the KE state, which is increasingly present at higher temperatures, is the same intermediate that is detected by time-resolved FTIR prior to its decay, on a time scale of hundreds of nanoseconds at ambient temperature (Dioumaev and Braiman, J. Phys. Chem. B 1997, 101, 1655−1662), into the KL state. We were unable to trap the latter separately from KE at low temperature, due to the slow distributed kinetics and the increasingly faster overlapping formation of the L state. Formation of the two consecutive K-like states in both proteins is accompanied by distortion of two different weakly bound water molecules: one in K0, the other in KE. The first, well-documented in bacteriorhodopsin at 77 K where K0 dominates, was assigned to water 401 in bacteriorhodopsin. The other water molecule, whose participation has not been described previously, is disturbed on the next step of the photocycle, in KE, in both proteins. In bacteriorhodopsin, the most likely candidate is water 407. However, unlike bacteriorhodopsin, the crystal structure of xanthorhodopsin lacks homologous weakly bound water molecules.

16 August 2024 in Chest
Verified
Journal Article
Closed access
JWJennifer M. Wang
Jennifer M. Wang
TATetsuro Araki
Tetsuro Araki
Vincent CottinVincent Cottin
Vincent Cottin
MHMeiLan K. Han
MeiLan K. Han
JOJustin M. Oldham
Justin M. Oldham